FR2806913B1 - Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale - Google Patents
Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosaleInfo
- Publication number
- FR2806913B1 FR2806913B1 FR0004120A FR0004120A FR2806913B1 FR 2806913 B1 FR2806913 B1 FR 2806913B1 FR 0004120 A FR0004120 A FR 0004120A FR 0004120 A FR0004120 A FR 0004120A FR 2806913 B1 FR2806913 B1 FR 2806913B1
- Authority
- FR
- France
- Prior art keywords
- mucosal
- adjuvant
- pharmaceutical composition
- aliphatic quaternary
- quaternary ammoniums
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0004120A FR2806913B1 (fr) | 2000-03-31 | 2000-03-31 | Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale |
AU48441/01A AU4844101A (en) | 2000-03-31 | 2001-04-02 | Use of aliphatic quaternary ammonium as adjuvant in a pharmaceutical compositionadministered by mucosal delivery |
PCT/FR2001/000984 WO2001074387A1 (fr) | 2000-03-31 | 2001-04-02 | Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale |
EP01921451A EP1267923A1 (fr) | 2000-03-31 | 2001-04-02 | Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0004120A FR2806913B1 (fr) | 2000-03-31 | 2000-03-31 | Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2806913A1 FR2806913A1 (fr) | 2001-10-05 |
FR2806913B1 true FR2806913B1 (fr) | 2003-01-31 |
Family
ID=8848716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0004120A Expired - Fee Related FR2806913B1 (fr) | 2000-03-31 | 2000-03-31 | Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1267923A1 (fr) |
AU (1) | AU4844101A (fr) |
FR (1) | FR2806913B1 (fr) |
WO (1) | WO2001074387A1 (fr) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5279833A (en) * | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
CA2126101A1 (fr) * | 1991-12-17 | 1993-06-24 | Robert J. Debs | Therapie genique de l'activite de regulation de la conductance transmembranaire dans la fibrose kystique (cftr) |
US5951988A (en) * | 1993-03-30 | 1999-09-14 | University Of Saskatchewan | Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods |
US5955077A (en) * | 1993-07-02 | 1999-09-21 | Statens Seruminstitut | Tuberculosis vaccine |
US5773011A (en) * | 1993-09-27 | 1998-06-30 | Gerbu Biotechnik Gmbh | Method of preparing a synergistic immunological adjuvant formulation |
KR19980067138A (ko) * | 1997-01-31 | 1998-10-15 | 박원훈 | 유전자 또는 생물학적 활성 약물을 세포내로 효과적으로 전달하는 지방 유제 및 그것의 제조방법 |
US6271200B1 (en) * | 1998-12-21 | 2001-08-07 | Generex Pharmaceuticals Inc. | Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
DK1183044T3 (da) * | 1999-05-12 | 2007-12-27 | Statens Seruminstitut | Adjuvanskombinationer til immunisering og vacciner |
DE60016205T2 (de) * | 1999-05-28 | 2005-12-01 | Vical, Inc., San Diego | Cytofectin-dimere und verfahren zu ihrer anwendung |
AU773778B2 (en) * | 1999-09-08 | 2004-06-03 | Watson Pharmaceuticals, Inc. | Using quaternary ammonium salts for transdermal drug delivery |
AU1738201A (en) * | 1999-10-26 | 2001-05-08 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Adjuvants for nucleic acid vaccines |
-
2000
- 2000-03-31 FR FR0004120A patent/FR2806913B1/fr not_active Expired - Fee Related
-
2001
- 2001-04-02 AU AU48441/01A patent/AU4844101A/en not_active Abandoned
- 2001-04-02 EP EP01921451A patent/EP1267923A1/fr not_active Withdrawn
- 2001-04-02 WO PCT/FR2001/000984 patent/WO2001074387A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2806913A1 (fr) | 2001-10-05 |
AU4844101A (en) | 2001-10-15 |
EP1267923A1 (fr) | 2003-01-02 |
WO2001074387A1 (fr) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2802655B1 (fr) | Compositions photosensibles comprenant des esters d'oximes comme photoamorceurs | |
ATE321569T1 (de) | Kombinierte impfstoffzusammensetzungen | |
FR2812883B1 (fr) | Utilisation d'inhibiteurs d'hppd comme agents de selection dans la transformation de plantes | |
ID29468A (id) | Komposisi farmasi yang stabil dalam bentuk liofil | |
IT1293509B1 (it) | Addensanti per composizioni acquose acide | |
DZ3177A1 (fr) | Copolymère comprenant l'acide isophtalique. | |
LU91306I2 (fr) | Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN) | |
NO20020086L (no) | Smaksmaskerte farmasöytiske flytende formuleringer | |
FR2793061B1 (fr) | Panneau d'affichage | |
FR2857263B1 (fr) | Nouvelle composition pharmaceutique solide comprenant de l'amisulpride | |
FR2823892B1 (fr) | Borne de stationnement payant pour une pluralite d'emplacements de stationnement | |
ID30508A (id) | Komposisi-komposisi yang mempunyai stabilitas yang lebih baik | |
IT1295355B1 (it) | Addensanti per composizioni acquose acide | |
FR2806913B1 (fr) | Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale | |
IT1313383B1 (it) | Struttura efficiente di integratore a capacita' commutate integrato | |
FR2798857B1 (fr) | Utilisation d'une proteine de membrane ompa d'enterobacterie associee a un peptide immunogene du vrs pour la preparation de vaccins administrables par voie nasale | |
FR2809473B1 (fr) | Support pour la fixation d'une tablette a une paroi | |
FR2818907B1 (fr) | Utilisation de la brivudine pour la preparation d'une composition pharmaceutique | |
FR2791889B1 (fr) | Suspension pharmaceutique buvable d'ibuprofene | |
FR2793140B1 (fr) | Utilisation de fragments d'acide hyaluronique | |
AU5089000A (en) | Improvements relating to builders' scaffolding | |
FR2796747B1 (fr) | Panneau d'affichage | |
FR2823204B1 (fr) | Preparation de sels d'acide perfluoroalcane sulfinique | |
UA2601S (uk) | Гра "географічна мозаїка" | |
UA3824S (uk) | Комплект етикеток "горілка "посольська" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20051130 |